COLL COLLEGIUM PHARMACEUTICAL INC Accounting Changes 8-K Filing 2023 - FDA Exclusivity Grant Collegium Pharmaceutical, Inc. announces that the FDA has granted New Patient Population exclusivity for Nucynta, extending its U.S. exclusivity period.Get access to all SEC 8-K filings of the COLLEGIUM PHARMACEUTICAL INC